Skip To Main Content
David Sans on Muck Rack

David Sans

(He/Him)
New York
As seen in: The Wall Street Journal, PR Newswire, GlobeNewswire, Capital Press, BioSpace, OC Today-Dispatch
Covers:  David started as Sr. Medical Scientist at Novartis during the launch of Glivec® (Imatinib) in Switzerland, Dir. of Market Analytics at Pfizer during the launch or Rebif® (interferon beta-1a for MS)
Back to David Sans’s profile

David Sans’s Journalist Portfolio

View as a list
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNB…

View article →
Merriman Capital Adds Health Care Investment Banker David Sans, Ph.D. To Financial Entrepreneur P...

Merriman Capital Adds Health Care Investment Banker David Sans, Ph.D. To Financial Entrepreneur P...

SAN FRANCISCO, Sept. 5, 2012 /PRNewswire/ -- Merriman Capital, Inc., a wholly owned subsidiary of Merriman Ho…

View article →
Speaker Bios (Subject to Change)

Speaker Bios (Subject to Change)

Investors - Dr. Al-Razouki has advised (and co-invested through Kleos) into lucrative healthcare opportunitie…

View article →
XORTX Appoints Dr. David Sans in New York as Director Corporate Development | BioSpace

XORTX Appoints Dr. David Sans in New York as Director Corporate Development | BioSpace

CALGARY, Alberta, Aug. 07, 2020 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc.. ("XORTX" or the "Company") (CSE:…

View article →
XORTX Appoints Dr. David Sans in New York as Director Corporate Development

XORTX Appoints Dr. David Sans in New York as Director Corporate Development

CALGARY, Alberta, Aug. 07, 2020 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (CSE: …

View article →
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNB…

View article →
Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participat...

TEL AVIV, Israel and BETHESDA, Md., Sept. 22, 2021 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNB…

View article →
David Sans Discusses Axonal Transport and How It Could Help Patients with Alzheimer's

David Sans Discusses Axonal Transport and How It Could Help Patients with Alzheimer's

Why David Sans in New York Believes Axonal Transport Can Be Key to Helping People with Alzheimer's NEW YORK, …

View article →
Calidi Biotherapeutics Appoints David Sans, FAARM, Ph.D., MBA, as Head of Corporate Development

Calidi Biotherapeutics Appoints David Sans, FAARM, Ph.D., MBA, as Head of Corporate Development

LA JOLLA, Calif.--()-- Calidi Biotherapeutics, Inc. (Calidi), a clinical-stage biotechnology company that is …

View article →
Our Team - Calidi Biotherapeutics

Our Team - Calidi Biotherapeutics

Chief Executive Officer Chairman of the Board of Directors

View article →
Dr. David Sans in New York appointed Chief of Corp. Dev. at CALIDI

Dr. David Sans in New York appointed Chief of Corp. Dev. at CALIDI

“We are thrilled to welcome David to the Calidi team as we continue to broaden our bench of executive talents…

View article →